
In a landmark development for Australia’s hemp sector, the Australian Pesticides and Veterinary Medicines Authority (APVMA) has clarified its regulatory stance on hemp‑derived animal nutrition products, effectively lifting previous ambiguities that halted the sale of hemp seed oil for pets. The APVMA’s decision follows a formal complaint submitted by the Australian Industrial Hemp Alliance (AIHA) and extensive industry advocacy.

In late 2024, the APVMA issued cease‑and‑desist notices to several hemp businesses marketing hemp seed oil supplements for companion animals, citing concerns over unregistered “veterinary chemical products.” This action surprised industry stakeholders, as hemp seed oil for human consumption has long been legal and widely used. The AIHA formally challenged the APVMA’s approach, arguing that hemp seed oil meeting Excluded Nutritional or Digestive (E.N.D.) criteria under the Agricultural and Veterinary Chemicals Code Act 1994 should be exempt from registration.
On 1 May 2025, APVMA CEO Scott Hansen acknowledged these concerns in a response letter to AIHA President Charles Kovess. The APVMA confirmed that:

Shortly after the APVMA’s letter, pet‑nutrition company HempPet issued a media release celebrating the shift. Since its 2020 launch, HempPet’s Full Spectrum HEMP DROPS—a prescription‑only cannabidiol (CBD)‑containing supplement for animals—has required veterinary oversight under existing regulations. The updated APVMA guidelines now explicitly eliminate prior restrictions on Australian‑grown hemp, reaffirming that pet‑safe hemp seed oil products can be prescribed by veterinarians without full VCP registration.

The APVMA encourages any company seeking to register new hemp‑based veterinary products to utilise its Pre‑Application Assistance service to navigate safety and efficacy requirements. Meanwhile, the AIHA and HempPet plan further engagement with the APVMA to refine the roadmap for emerging hemp‑derived inputs in animal health.